Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	2,509	2,408	2,880	3,498	6,509	4,405
Market Cap Growth	-28.84%	-16.40%	-17.67%	-46.25%	47.77%	64.01%
Enterprise Value	2,831	2,436	2,799	3,183	6,017	4,138
Last Close Price	19.90	19.37	26.87	33.05	62.43	43.06
PS Ratio	1003.74	678.12	11.96	14.38	47.07	50.06
PB Ratio	47.52	12.60	10.03	8.36	15.92	9.54
P/TBV Ratio	52.63	13.61	11.03	9.05	16.47	9.87
P/FCF Ratio	-	-	-	-	44.05	-
P/OCF Ratio	-	-	-	-	37.99	-
EV/Sales Ratio	1132.23	686.02	11.63	13.09	43.51	47.03
EV/FCF Ratio	-	-	-	-	40.72	-
Debt / Equity Ratio	15.55	4.46	1.34	0.19	0.06	0.05
Debt / FCF Ratio	-	-	-	-	0.17	-
Asset Turnover	0.00	0.00	0.33	0.35	0.22	0.20
Quick Ratio	5.90	6.57	3.75	2.67	2.58	7.78
Current Ratio	6.09	6.74	3.95	2.92	2.62	7.92
Return on Equity (ROE)	-565.33%	-254.98%	-59.33%	-42.67%	-32.36%	-23.96%
Return on Assets (ROA)	-47.71%	-39.43%	-17.58%	-15.91%	-15.11%	-13.35%
Return on Capital (ROIC)	-52.37%	-43.85%	-21.89%	-23.88%	-20.31%	-16.02%
Earnings Yield	-25.49%	-24.90%	-7.13%	-5.03%	-2.16%	-1.92%
FCF Yield	-22.78%	-25.10%	-11.48%	-5.40%	2.27%	-2.45%
Buyback Yield / Dilution	-15.92%	-12.21%	-1.26%	-1.62%	-3.00%	-2.14%
Total Shareholder Return	-15.92%	-12.21%	-1.26%	-1.62%	-3.00%	-2.14%

Source: S&P Capital IQ. Standard template. Financial Sources.